Pluri Inc. (PLUR) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
29/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LosePLUR / S&P -38.53% / 15.20% |
LosePLUR / S&P PLUR unavailable / 15.00% |
LosePLUR / S&P PLUR unavailable / 50.40% |
| 2026-Q11/3 |
WinPLUR / S&P 13.71% / -4.33% |
LosePLUR / S&P 4.35% / 11.30% |
LosePLUR / S&P -19.61% / 27.70% |
| 2025-Q41/3 |
LosePLUR / S&P -33.26% / 2.65% |
WinPLUR / S&P 97.49% / 9.00% |
LosePLUR / S&P -10.57% / 13.40% |
| 2025-Q31/3 |
LosePLUR / S&P -9.49% / 8.12% |
WinPLUR / S&P 121.74% / 4.61% |
LosePLUR / S&P -24.27% / 13.45% |
| 2025-Q22/3 |
WinPLUR / S&P 15.12% / 10.94% |
WinPLUR / S&P 309.82% / 4.83% |
LosePLUR / S&P -11.25% / 10.63% |
| 2025-Q12/3 |
WinPLUR / S&P 0.47% / -4.27% |
WinPLUR / S&P 203.23% / 4.98% |
LosePLUR / S&P -12.35% / 10.57% |
| 2024-Q41/3 |
LosePLUR / S&P -29.26% / 2.41% |
WinPLUR / S&P 89.92% / 5.25% |
LosePLUR / S&P -20.47% / 6.15% |
| 2024-Q31/3 |
LosePLUR / S&P 4.67% / 5.89% |
WinPLUR / S&P 135.43% / 5.89% |
LosePLUR / S&P 5.10% / 6.11% |
| 2024-Q22/3 |
LosePLUR / S&P -10.80% / 4.28% |
WinPLUR / S&P 13.59% / 5.38% |
WinPLUR / S&P 26.98% / 5.12% |
| 2024-Q13/3 |
WinPLUR / S&P 39.66% / 10.56% |
WinPLUR / S&P 93.75% / 5.71% |
WinPLUR / S&P 85.20% / 5.59% |
| 2023-Q42/3 |
LosePLUR / S&P -3.33% / 11.69% |
WinPLUR / S&P 10.53% / 6.81% |
WinPLUR / S&P 354.90% / 7.78% |
| 2023-Q31/3 |
LosePLUR / S&P -25.00% / -3.27% |
LosePLUR / S&P PLUR unavailable / 7.52% |
WinPLUR / S&P 250.00% / -5.03% |
| 2023-Q21/3 |
LosePLUR / S&P -21.57% / 8.74% |
LosePLUR / S&P PLUR unavailable / 9.50% |
WinPLUR / S&P 144.19% / -8.57% |
| 2023-Q11/3 |
WinPLUR / S&P 8.51% / 7.50% |
LosePLUR / S&P PLUR unavailable / 10.77% |
LosePLUR / S&P PLUR unavailable / -15.69% |
| 2022-Q41/3 |
WinPLUR / S&P 20.51% / 7.56% |
LosePLUR / S&P PLUR unavailable / 11.88% |
LosePLUR / S&P PLUR unavailable / -17.99% |
| 2022-Q30/3 |
LosePLUR / S&P -36.59% / -4.88% |
LosePLUR / S&P PLUR unavailable / 13.47% |
LosePLUR / S&P PLUR unavailable / -1.41% |
| 2022-Q20/3 |
LosePLUR / S&P -40.58% / -16.10% |
LosePLUR / S&P PLUR unavailable / 13.71% |
LosePLUR / S&P PLUR unavailable / 11.04% |
| 2022-Q11/3 |
WinPLUR / S&P 41.78% / -4.60% |
LosePLUR / S&P PLUR unavailable / 15.97% |
LosePLUR / S&P PLUR unavailable / 42.23% |
| 2021-Q40/3 |
LosePLUR / S&P -44.91% / 11.03% |
LosePLUR / S&P PLUR unavailable / 15.00% |
LosePLUR / S&P PLUR unavailable / 96.40% |
| 2021-Q30/3 |
LosePLUR / S&P -33.08% / 0.58% |
LosePLUR / S&P PLUR unavailable / 10.77% |
LosePLUR / S&P PLUR unavailable / 69.42% |
| 2021-Q20/3 |
LosePLUR / S&P -16.98% / 8.55% |
LosePLUR / S&P PLUR unavailable / 6.58% |
LosePLUR / S&P PLUR unavailable / 51.81% |
| 2021-Q10/3 |
LosePLUR / S&P -32.53% / 6.17% |
LosePLUR / S&P PLUR unavailable / -1.06% |
LosePLUR / S&P PLUR unavailable / 7.39% |
| 2020-Q40/3 |
LosePLUR / S&P -32.86% / 12.15% |
LosePLUR / S&P PLUR unavailable / -3.72% |
LosePLUR / S&P PLUR unavailable / -33.42% |
| 2020-Q31/3 |
WinPLUR / S&P 19.12% / 8.93% |
LosePLUR / S&P PLUR unavailable / -2.04% |
LosePLUR / S&P PLUR unavailable / -27.10% |
| 2020-Q21/3 |
WinPLUR / S&P 140.87% / 20.54% |
LosePLUR / S&P PLUR unavailable / -0.46% |
LosePLUR / S&P PLUR unavailable / -27.11% |
| 2020-Q11/3 |
WinPLUR / S&P -6.85% / -19.60% |
LosePLUR / S&P PLUR unavailable / 3.47% |
LosePLUR / S&P PLUR unavailable / -14.75% |
| 2019-Q40/3 |
LosePLUR / S&P 5.35% / 9.07% |
LosePLUR / S&P PLUR unavailable / 5.36% |
LosePLUR / S&P PLUR unavailable / 2.99% |
| 2019-Q30/3 |
LosePLUR / S&P -39.68% / 1.70% |
LosePLUR / S&P PLUR unavailable / 5.02% |
LosePLUR / S&P PLUR unavailable / 0.21% |
| 2019-Q20/3 |
LosePLUR / S&P -36.08% / 4.30% |
LosePLUR / S&P PLUR unavailable / 6.64% |
LosePLUR / S&P PLUR unavailable / 8.65% |
| 2019-Q11/3 |
WinPLUR / S&P 22.78% / 13.65% |
LosePLUR / S&P PLUR unavailable / 8.12% |
LosePLUR / S&P PLUR unavailable / 14.29% |
| 2018-Q40/3 |
LosePLUR / S&P -39.23% / -13.52% |
LosePLUR / S&P PLUR unavailable / 9.05% |
LosePLUR / S&P PLUR unavailable / 18.23% |
| 2018-Q30/3 |
LosePLUR / S&P 6.56% / 7.71% |
LosePLUR / S&P PLUR unavailable / 10.21% |
LosePLUR / S&P PLUR unavailable / 19.06% |
| 2018-Q20/3 |
LosePLUR / S&P -10.95% / 3.43% |
LosePLUR / S&P PLUR unavailable / 9.03% |
LosePLUR / S&P PLUR unavailable / 14.46% |
| 2018-Q11/3 |
WinPLUR / S&P -0.72% / -0.76% |
LosePLUR / S&P PLUR unavailable / 7.68% |
LosePLUR / S&P PLUR unavailable / 12.46% |
| 2017-Q40/3 |
LosePLUR / S&P -8.61% / 6.64% |
LosePLUR / S&P PLUR unavailable / 7.03% |
LosePLUR / S&P PLUR unavailable / 13.82% |
| 2017-Q31/3 |
WinPLUR / S&P 17.97% / 4.48% |
LosePLUR / S&P PLUR unavailable / 5.68% |
LosePLUR / S&P PLUR unavailable / 17.57% |
| 2017-Q21/3 |
WinPLUR / S&P 4.07% / 3.09% |
LosePLUR / S&P PLUR unavailable / 4.83% |
LosePLUR / S&P PLUR unavailable / 17.74% |
| 2017-Q10/3 |
LosePLUR / S&P -13.99% / 6.07% |
LosePLUR / S&P PLUR unavailable / 3.67% |
LosePLUR / S&P PLUR unavailable / 13.32% |
| 2016-Q40/3 |
LosePLUR / S&P -10.62% / 3.82% |
LosePLUR / S&P PLUR unavailable / 2.09% |
LosePLUR / S&P PLUR unavailable / 7.05% |
| 2016-Q31/3 |
WinPLUR / S&P 20.30% / 3.85% |
LosePLUR / S&P PLUR unavailable / 0.20% |
LosePLUR / S&P PLUR unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | PLUR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -70.97% | 20.78% |
| Annualized return | -70.97% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | PLUR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -93.85% | 83.14% |
| Annualized return | -42.75% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | PLUR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -98.83% | 319.30% |
| Annualized return | -35.93% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |